Skip to main content
. 2018 Feb 1;38(9):998–1010. doi: 10.1093/asj/sjy008

Figure 7.

Figure 7.

Representative photographs and efficacy results at baseline (A [front facing] and C [right facing]) and 12 weeks after last treatment with ATX-101 (B [front facing] and D [right facing]). 22-year-old female who received 4 ATX-101 treatment sessions (total volume: 23.2 mL) and achieved a 2-grade improvement in submental fat based on both clinician and patient assessment. At baseline, CR-SMFRS was moderate (2); PR-SMFRS was moderate (2); SSRS was extremely dissatisfied (0); PR-SMFIS TSS was 7.0/10 (greatest negative impact); SMSLG was none (1); and BMI was 27.0 kg/m2. At 12 weeks after last treatment, CR-SMFRS was absent (0); PR-SMFRS was none (0); SSRS was extremely satisfied (6); PR-SMFIS TSS was 0.8; SMSLG was none (1); and BMI was 25.2 kg/m2. BMI, body mass index; CR-SMFRS, Clinician-Reported SMF Rating Scale; PR-SMFIS, Patient-Reported SMF Impact Scale; PR-SMFRS, Patient-Reported SMF Rating Scale; SMSLG, Submental Skin Laxity Grade; SSRS, Subject Self-Rating Scale; TSS, total scale score.